Daiichi Sankyo
Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.
DitchCarbon Score
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo's score of 71 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Daiichi Sankyo's reported carbon emissions
In 2024, Daiichi Sankyo reported total carbon emissions of approximately 4,274,477,000 kg CO2e, with Scope 1 emissions at about 89,118,000 kg CO2e, Scope 2 emissions at approximately 24,888,000 kg CO2e, and a significant Scope 3 contribution of around 4,160,471,000 kg CO2e. The combined Scope 1 and 2 emissions totalled about 114,006,000 kg CO2e. For the previous year, 2023, the company recorded total emissions of approximately 4,517,975,000 kg CO2e globally, with Scope 1 emissions at about 85,245,000 kg CO2e and Scope 2 emissions at approximately 23,994,000 kg CO2e. The Scope 3 emissions for that year were around 4,408,736,000 kg CO2e. Daiichi Sankyo has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions by FY2050. This includes a target to reduce absolute Scope 1 and 2 emissions by 63% by FY2030 from a FY2015 baseline. Additionally, the company plans to increase its sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, it aims for 70.6% of its suppliers, by emissions, to have science-based targets by FY2025. The company has also established near-term targets, committing to a 42% reduction in Scope 1 and 2 emissions by 2030 from a 2023 base year, while also focusing on measuring and reducing its Scope 3 emissions. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a commitment to sustainable practices within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 182,519,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 290,715,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 5,704,000 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
